Sab Biotherapeutics, Inc. · NASDAQ:SABS
Rtw Investments, LP reported a 9.99% stake in Sab Biotherapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Rtw Investments, LP reported a 9.99% stake in Sab Biotherapeutics, Inc., 1,024,335 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 1,024,335
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RTW Investments, LP | 9.99% | 1,024,335 |
| Roderick Wong, M.D. | 9.99% | 1,024,335 |
Source
Related
- Sab Biotherapeutics, Inc.
- Rtw Investments, LP
- Sab Biotherapeutics, Inc. shareholders
- Schedule 13G/A · Rtw Investments, LP · Feb 17, 2026
- Form 4 · Kropotova Alexandra · Sep 18, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Caligan Partners LP · Aug 14, 2026